港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

九源基因

9.820

+0.0900.92%

成交量：94.20萬

成交額：919.30萬

市值：24.06億

市盈率：13.23

高：9.910

開：9.730

低：9.630

收：9.730

資料載入中...

總覽公司新聞公告

九源基因06月11日主力淨流入71.2萬元散戶資金拋售

國產GLP-1概念股大漲，千億盛宴來了

九源基因(02566)股價顯著上升11.129%，現價港幣$6.89

阿斯达克财经

九源基因05月30日主力淨流入14.0萬元散戶資金拋售

吉藥退市，九源基因攜手復星出海，譽衡拿下一原研藥推廣權

医药经济报

復星醫藥與九源基因簽署多款生物藥及創新藥械產品海外獨家商業化協議

復星醫藥與九源基因簽署多款生物藥及創新藥械產品海外獨家商業化協議

九源基因05月26日遭主力拋售25.4萬元

九源基因：2024年腫瘤產品佔營收19.47%，血液產品佔9.96%

【九源基因(02566.HK)將於7月30日派發末期股息每10股0.56元】九源基因(02566.HK)發佈公告，該公司將於2025年7月30日派發末期股息每10股0.56元人民幣。

九源基因(02566)將於7月30日派發末期股息每10股0.56元

九源基因：2024年收益達人民幣1,369.2百萬元，同比增長6.4%

九源基因04月09日主力淨流入35萬元散户資金拋售

九源基因04月07日遭主力拋售110萬元

九源基因完成名稱更改登記手續新名稱正式生效

九源基因(02566)完成名稱更改登記手續新名稱正式生效

智通财经网

九源基因：2024年公司營業收入同比增長6.4%，毛利率提升至79%

九源基因03月28日主力淨流出23萬元散戶資金買入

九源基因去年淨利增超15%，減重版司美格魯肽或明年上半年提交上市申請

九源基因2024年營收13.69億元：“司美”首個仿製藥申報者，押寶“網紅”賽道尋新增長

21世纪经济报道

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02566/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":9.82,"timestamp":1752653287016,"preClose":9.73,"halted":0,"volume":942000,"delay":0,"floatShares":109000000,"shares":245000000,"eps":0.7420779625399366,"marketStatus":"未開盤","change":0.09,"latestTime":"07-16 16:08:07","open":9.73,"high":9.91,"low":9.63,"amount":9193008,"amplitude":0.028777,"askPrice":9.82,"askSize":12200,"bidPrice":9.78,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.7420779625399366,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":0,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":9.73,"dividendRate":0.006183,"openAndCloseTimeList":[[1752629400000,1752638400000],[1752642000000,1752652800000]],"volumeRatio":0.790746,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":109000000,"roa":"6.08%","roe":"11.47%","lyrEps":0.742078,"volumeRatio":0.790746,"shares":245000000,"dividePrice":0.061233,"high":9.91,"amplitude":0.028777,"preClose":9.73,"low":9.63,"week52Low":5.151,"pbRate":"1.45","psRate":"1.61","week52High":11.84,"institutionHeld":0,"latestPrice":9.82,"committee":-0.71831,"eps":0.7420779625399366,"divideRate":0.006236,"volume":942000,"delay":0,"ttmEps":0.7420779625399366,"open":9.73,"prevYearClose":6.563,"prevWeekClose":9.61,"prevMonthClose":7.85,"prevQuarterClose":7.85,"fiveDayClose":9.09,"twentyDayClose":8.95,"sixtyDayClose":5.887},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542302745","title":"九源基因06月11日主力淨流入71.2萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2542302745","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542302745?lang=zh_tw&edition=fundamental","pubTime":"2025-06-11 16:15","pubTimestamp":1749629723,"startTime":"0","endTime":"0","summary":"06月11日, 九源基因股价涨2.04%，报收7.50元，成交金额1127.0万元，换手率1.33%，振幅8.30%，量比3.00。九源基因今日主力资金净流入71.2万元，上一交易日主力净流出94.2万元。该股近5个交易日上涨19.24%，主力资金累计净流入228.1万元；近20日主力资金累计净流入203.8万元，其中净流入天数为3日。该股主力净额占比0.09%，港股市场排名136/2657。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611173118a4a34869&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611173118a4a34869&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2542203315","title":"國產GLP-1概念股大漲，千億盛宴來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2542203315","media":"21新健康","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542203315?lang=zh_tw&edition=fundamental","pubTime":"2025-06-10 18:27","pubTimestamp":1749551269,"startTime":"0","endTime":"0","summary":"目前，GLP-1靶点在肥胖治疗中的价值已获得广泛认可，以司美格鲁肽为代表的GLP-1受体激动剂类药物风靡全球。据行业预测，2025年全球GLP-1药物市场规模将突破600亿美元，中国市场规模预计达45亿美元，年增长率超28%。华东医药则具备明显的先发和渠道优势，其利拉鲁肽注射液在2023年7月获批中国首个GLP-1减重适应证，目前已覆盖全国超1000家医院及2万家药店。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610184235a4a1d25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610184235a4a1d25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","BK0239","688076","02566","688117"],"gpt_icon":0},{"id":"2542728238","title":"九源基因(02566)股價顯著上升11.129%，現價港幣$6.89","url":"https://stock-news.laohu8.com/highlight/detail?id=2542728238","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542728238?lang=zh_tw&edition=fundamental","pubTime":"2025-06-09 13:05","pubTimestamp":1749445500,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在下午01:05比前收市价显著上升11.129%，现股价为港币$6.89。至目前为止，今日最高价为$6.95，而最低价为$6.2。总成交量为54.42万股，总成交金额为港币$359.315万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2506093843/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2539228107","title":"九源基因05月30日主力淨流入14.0萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2539228107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539228107?lang=zh_tw&edition=fundamental","pubTime":"2025-05-30 16:15","pubTimestamp":1748592923,"startTime":"0","endTime":"0","summary":"05月30日, 九源基因股价涨0.32%，报收6.24元，成交金额65.3万元，换手率0.10%，振幅5.63%，量比0.90。九源基因今日主力资金净流入14.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.97%，主力资金累计净流出11.5万元；近20日主力资金累计净流出0.6万元，其中净流出天数为2日。该股主力净额占比0.02%，港股市场排名207/2657。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530172809a492998e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530172809a492998e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2539217471","title":"吉藥退市，九源基因攜手復星出海，譽衡拿下一原研藥推廣權","url":"https://stock-news.laohu8.com/highlight/detail?id=2539217471","media":"医药经济报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539217471?lang=zh_tw&edition=fundamental","pubTime":"2025-05-30 13:39","pubTimestamp":1748583592,"startTime":"0","endTime":"0","summary":"5月29日，上市15年的吉药控股正式退市。也是在这一年，吉药控股出现了上市以来的首次年度亏损。九源基因携手复星医药出海5月28日，复星医药宣布已与九源基因就多款生物药及创新药械产品的海外独家商业化权益合作签署协议。而兴和制药将按照协议约定向誉衡药业支付服务费及推广支持费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530134448a6f2cf7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530134448a6f2cf7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2538473637","title":"復星醫藥與九源基因簽署多款生物藥及創新藥械產品海外獨家商業化協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2538473637","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538473637?lang=zh_tw&edition=fundamental","pubTime":"2025-05-28 19:34","pubTimestamp":1748432054,"startTime":"0","endTime":"0","summary":"人民财讯5月28日电，近日，上海复星医药（集团）股份有限公司（简称“复星医药”）与杭州九源基因生物药股份有限公司（简称“九源基因”）就多款生物药及创新药械产品的海外独家商业化权益合作在杭州举办签约仪式。根据协议，复星医药获得九源基因的独家授权，就司美格鲁肽、骨优导和JY-23等产品，在中东北非、撒哈拉以南非洲全部国家及部分东盟国家的独家临床开发、注册、生产和商业化权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505283416933179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK1515","BK1191","02566","02196"],"gpt_icon":0},{"id":"2538478902","title":"復星醫藥與九源基因簽署多款生物藥及創新藥械產品海外獨家商業化協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2538478902","media":"E公司","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538478902?lang=zh_tw&edition=fundamental","pubTime":"2025-05-28 19:24","pubTimestamp":1748431491,"startTime":"0","endTime":"0","summary":"人民财讯5月28日电，近日，上海复星医药（集团）股份有限公司（简称“复星医药”）与杭州九源基因生物药股份有限公司（简称“九源基因”）就多款生物药及创新药械产品的海外独家商业化权益合作在杭州举办签约仪式。根据协议，复星医药获得九源基因的独家授权，就司美格鲁肽、骨优导和JY-23等产品，在中东北非、撒哈拉以南非洲全部国家及部分东盟国家的独家临床开发、注册、生产和商业化权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528192451a48fc50e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528192451a48fc50e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0183","BK0060","BK0096","BK0187","600196","159839","399265","02196","BK0028","BK0188","BK0196","BK0175","02566","BK0239"],"gpt_icon":0},{"id":"2538865172","title":"九源基因05月26日遭主力拋售25.4萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538865172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538865172?lang=zh_tw&edition=fundamental","pubTime":"2025-05-26 16:15","pubTimestamp":1748247326,"startTime":"0","endTime":"0","summary":"05月26日, 九源基因股价跌2.59%，报收6.02元，成交金额93.1万元，换手率0.14%，振幅4.85%，量比1.24。九源基因今日主力资金净流出25.4万元，上一交易日主力净流出12.8万元。该股近5个交易日下跌2.43%，主力资金累计净流出38.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出14.6万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526172056a48cc489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526172056a48cc489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2531216765","title":"九源基因：2024年腫瘤產品佔營收19.47%，血液產品佔9.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216765","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531216765?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:25","pubTimestamp":1745889900,"startTime":"0","endTime":"0","summary":"来源：Gangtise投研九源基因（02566.HK）2024年度业绩发布会：九源基因成立于1993年，专注生物医药领域，拥有9款商业化产品，涵盖肿瘤、骨科、血液和代谢四大领域。2024年肿瘤产品占营收19.47%，血液产品占9.96%。其骨科重点产品为国内首款含RHBNP蛋白的骨复合材料，适用于多种骨修复场景。公司正布局院内和院外市场，尤其注重线上互联网药店合作，已与近岸蛋白签署合作协议，共同开发透明质酸酶平台，旨在提升药物渗透分散性，实现给药方式创新。责任编辑：王若云","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092636a6cc6f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092636a6cc6f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2529648030","title":"【九源基因(02566.HK)將於7月30日派發末期股息每10股0.56元】九源基因(02566.HK)發佈公告，該公司將於2025年7月30日派發末期股息每10股0.56元人民幣。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529648030","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529648030?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:23","pubTimestamp":1745468623,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK)发布公告，该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24122349819418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2529486816","title":"九源基因(02566)將於7月30日派發末期股息每10股0.56元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529486816","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529486816?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:20","pubTimestamp":1745468433,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2529364877","title":"九源基因：2024年收益達人民幣1,369.2百萬元，同比增長6.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529364877","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529364877?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:13","pubTimestamp":1745467984,"startTime":"0","endTime":"0","summary":"金融界4月24日消息，九源基因公布2024年年报，期内收益为人民币1,369.2百万元，同比增长6.4%；母公司股东应占年内溢利为人民币138.6百万元；每股基本盈利为人民币0.68元。以上数据未经审核。\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/24121349819071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2526333230","title":"九源基因04月09日主力淨流入35萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526333230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526333230?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 16:16","pubTimestamp":1744186609,"startTime":"0","endTime":"0","summary":"04月09日, 九源基因股价涨1.04%，报收5.84元，成交金额101万元，换手率0.17%，振幅8.30%，量比0.67。九源基因今日主力资金净流入35万元，上一交易日主力净流出0万元。该股近5个交易日下跌12.84%，主力资金累计净流出95万元；近20日主力资金累计净流出153万元，其中净流出天数为5日。该股主力净额占比0.06%，港股市场排名159/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409171009a6b53a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409171009a6b53a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2525609463","title":"九源基因04月07日遭主力拋售110萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525609463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525609463?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 16:16","pubTimestamp":1744013784,"startTime":"0","endTime":"0","summary":"04月07日, 九源基因股价跌14.26%，报收5.59元，成交金额464万元，换手率0.74%，振幅10.43%，量比5.06。九源基因今日主力资金净流出110万元，上一交易日主力净流出20万元。该股近5个交易日下跌20.93%，主力资金累计净流出130万元；近20日主力资金累计净流出116万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407170716a6b26ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407170716a6b26ea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2524464157","title":"九源基因完成名稱更改登記手續 新名稱正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2524464157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524464157?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 17:26","pubTimestamp":1743585999,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，继公司股东通过特别决议案批准更改公司名称后，截至本公告日期，公司已就更改公司名称向中国相关政府机关完成登记手续，并已取得换发的营业执照。因此，更改公司名称自本公告日期起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040219110794c9b7c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040219110794c9b7c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2524245764","title":"九源基因(02566)完成名稱更改登記手續 新名稱正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2524245764","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524245764?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 17:26","pubTimestamp":1743585960,"startTime":"0","endTime":"0","summary":"九源基因(02566)发布公告，继公司股东通过特别决议案批准更改公司名称后，截至本公告日期，公司已就更改公司名称向中国相关政府机关完成登记手续，并已取得换发的营业执照。因此，更改公司名称自本公告日期起生效。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-02/doc-inerupah5254491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2523932250","title":"九源基因：2024年公司營業收入同比增長6.4%，毛利率提升至79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523932250","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523932250?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 09:29","pubTimestamp":1743384540,"startTime":"0","endTime":"0","summary":"　　九源基因2024年度业绩发布会：九源基因2024年度业绩发布会介绍了公司经营亮点与未来规划。公司营业收入达13.69亿人民币，同比增长6.4%，毛利率提升至79%，核心产品保持高增速，生物药近3~4年平均增幅21.7%。公司2024年上市，引入多家战略投资人，公众认购倍数超670倍。研发方面，2024年JY06获上市批准，JY54等多款在研产品聚焦骨科、代谢等领域，未来有望推出多款新品。未来公司将持续拓展业务，提升市场份额，预计2025年营收增速达10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-31/doc-inerpcsu7347851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2522547686","title":"九源基因03月28日主力淨流出23萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2522547686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522547686?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 16:16","pubTimestamp":1743149773,"startTime":"0","endTime":"0","summary":"03月28日, 九源基因股价跌1.26%，报收7.07元，成交金额86万元，换手率0.11%，振幅3.63%，量比0.93。九源基因今日主力资金（超大单+大单）净流出23万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.47%，主力资金累计净流出23万元；近20日主力资金累计净流入64万元，其中净流入天数为3日。该股主力净额占比0.03%（主力资金净额/流通市值），港股市场排名2469/2650。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165457a6a73347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165457a6a73347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2522302862","title":"九源基因去年淨利增超15%，減重版司美格魯肽或明年上半年提交上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2522302862","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522302862?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 22:14","pubTimestamp":1743084840,"startTime":"0","endTime":"0","summary":"手握司美格鲁肽生物类似药的九源基因公布港股上市后首份业绩公告。九源基因司美格鲁肽JY29-2治疗糖尿病适应证于2024年4月国内第一家申报生产文号，治疗肥胖和超重适应证进入三期临床，并完成全部病例入组。在3月27日的业绩交流会上，九源基因相关负责人提到，减重适应证2026年上半年报产。预计2025年内向巴西、沙特递交司美格鲁肽的新药申请。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-03-27/doc-inerceuh0520899.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-27/doc-inerceuh0520899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2522317409","title":"九源基因2024年營收13.69億元：“司美”首個仿製藥申報者，押寶“網紅”賽道尋新增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2522317409","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522317409?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 14:55","pubTimestamp":1743058500,"startTime":"0","endTime":"0","summary":"3月26日，九源基因发布的业绩公告显示，该公司2024年实现总收入13.69亿元，同比增长6.4%；净利润1.386亿元，同比增长15.7%。九源基因的招股书数据显示，公司在2021年、2022年、2023年的营收分别为13.07亿元、11.25亿元、12.87亿元，净利润分别为1.19亿元、5986.7万元、1.20亿元。近两年，九源基因因成为“国内首个司美格鲁肽仿制药申报者”而备受瞩目。九源基因迅速抓住申报的先机，一时成为资本市场关注的焦点。面对困境，九源基因必须寻找新的突破口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327150315a4439716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327150315a4439716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"},{"date":"2025-03-26","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"","dateTimestamp":1742918400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2025-07-15","current":16.321974,"percent":0.966443,"low":9.307514,"twenty":10.199879,"median":11.378042,"eighty":13.210239,"high":18.134776,"avg":11.817604,"sd":1.847264,"marketCap":2387730324},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-09","current":10.406872,"twenty":10.062805,"median":11.203375,"eighty":12.472285,"marketCap":1494478692},{"date":"2025-05-16","current":10.339488,"twenty":10.073062,"median":11.154484,"eighty":12.457737,"marketCap":1496932680},{"date":"2025-05-23","current":10.443848,"twenty":10.076938,"median":11.100884,"eighty":12.429027,"marketCap":1516564584},{"date":"2025-05-30","current":10.499086,"twenty":10.079206,"median":11.063697,"eighty":12.408842,"marketCap":1531288512},{"date":"2025-06-06","current":10.405237,"twenty":10.102813,"median":10.92653,"eighty":12.402573,"marketCap":1521472560},{"date":"2025-06-13","current":16.776007,"twenty":10.127345,"median":11.063697,"eighty":12.429027,"marketCap":2453988000},{"date":"2025-06-20","current":13.783342,"twenty":10.148232,"median":11.100884,"eighty":12.535947,"marketCap":2012270160},{"date":"2025-06-27","current":13.241991,"twenty":10.175286,"median":11.154484,"eighty":12.72799,"marketCap":1938650520},{"date":"2025-07-04","current":14.247042,"twenty":10.191457,"median":11.198369,"eighty":12.80722,"marketCap":2085889800},{"date":"2025-07-11","current":16.12378,"twenty":10.199228,"median":11.287756,"eighty":13.164345,"marketCap":2358282468},{"date":"2025-07-15","current":16.321974,"twenty":10.199879,"median":11.378042,"eighty":13.210239,"marketCap":2387730324}],"updateTime":1752688609698}}}